Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS).
Waqas T QureshiIngrid D SantarenAnthony J HanleySteven M WatkinsCarlos LorenzoLynne E WagenknechtPublished in: BMJ open diabetes research & care (2019)
We observed associations of DNL fatty acids with type 2 diabetes incidence independent of insulin sensitivity.